Fibrocell Science, Inc. (FCSC)

Check out top investors' recommendation for FCSC
Last closing price (N/A)
(0.00%) ? 
Last closing price is the stock price upon last market close (date specified in parenthesis).
Return to date (1m/3m/6m/12m):
N/A ? 
Return to date is the stock return for the specified period of time.
Consensus price target (1m/3m/6m/12m):
N/A
 ? 
Consensus price target is the average analyst price target for a specified period of time.
Buy/Sell Mix (1m/3m/6m/12m):
N/A
 ? 
Buy/sell mix the percentage mix between Buy and Sell recommendations for a given company or a research firm. Hold recommendations are excluded.
Description:
Fibrocell Science, Inc., an autologous cellular therapeutic company, together with its subsidiaries, focuses on development of various products for aesthetic, medical, and scientific applications. The company offers LAVIV, a personalized aesthetic cell therapy for the improvement of the appearance of moderate to severe nasolabial fold wrinkles in adults. Its clinical and pre-clinical programs include treatments for restrictive burn scars, vocal cord scars, and acne scars. The company also develops Fibrocell Science Autologous Crème, an autologous skin care cream. Fibrocell Science, Inc. has a collaboration agreement with Intrexon Corporation to discover and develop treatments for collagen deficient diseases, such as recessive dystrophic epidermolysis bullosa. The company was formerly known as Isolagen, Inc. and changed its name to Fibrocell Science, Inc. in September 2009. Fibrocell Science, Inc. was founded in 1995 and is headquartered in Exton, Pennsylvania.
Sector:
Industry:
Analyst
An analyst is a professional research analyst or an Investor Wand user who issued a recommendation for a given company.
Research Firm
A Research Firm is a company that researches and rates stocks and publishes recommendations.
Signal
Signal is a recommendation issued by an analyst. Investor Wand considers two types of recommendations: BUY and SELL.
Signal Date
A signal date is a date when a BUY or SELL recommendation was issued for given security.
Initial Price
Initial Price is the first closing price for a specified company upon recommendation release. If the recommendation is issued in after-market hours, the Initial Price is the next day’s closing price (for a given symbol). In case of dividend distributions and stock splits, Initial Price is adjusted.
Price Target
A Price Target is an analyst’s projection of a company’s stock price by the end of the recommendation period. It represents the price at which the analyst would exit his or her existing position.
Closing Date
Closing Date is the expiration date of a recommendation. The validity timeframe of a professional analyst’s recommendation is 12 months. Investor Wand analysts can set their recommendation timeframe to one, three, six, or 12 months.
Return
The return on a single open recommendation is calculated as the maximum of the current return (based on the latest closing price) and the target price return, if the symbol reached the target. The return on a single closed recommendation is calculated as the maximum of the return on the closing date (at the end of recommendation timeframe) and the target price return, if the stock hit the target price. The return is adjusted for one-time events (e.g., stock splits).
Joseph Pantginis Roth Capital Partners LLC Buy   Aug 09, '18     22.00  Aug 09, '19  N/A 
Joseph Pantginis Roth Capital Partners LLC Buy   Jun 05, '18     22.00  Jun 05, '19  N/A 
Joseph Pantginis Roth Capital Partners LLC Buy   Mar 06, '18     6.00  Mar 06, '19  N/A 
Joseph Pantginis Roth Capital Partners LLC Buy   Jan 16, '18     6.00  Jan 16, '19  N/A 
Joseph Pantginis Roth Capital Partners LLC Buy   Sep 15, '17     5.70  Sep 15, '18  N/A 
Joseph Pantginis Roth Capital Partners LLC Buy   Aug 09, '17     5.70  Aug 09, '18  N/A